Standard Chartered: The US dollar ends its undervaluation and returns to historical normal levels
According to ChainCatcher, citing Golden Ten Data, Steve Englander from Standard Chartered Bank stated in a report that the US dollar deviated over the past year and is now returning to its normal relationship with historical drivers. Englander pointed out that the US dollar was overvalued at the end of 2024 and the beginning of 2025, then turned undervalued in the second quarter and early third quarter of 2025, and is now almost balanced. He believes that the reduction in the undervaluation of the US dollar is positive for the currency.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.


